Rhode Island Hospital-Lifespan Cancer Institute is a clinical research site located in Providence, Rhode Island, United States 02903.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Rhode Island Hospital-Lifespan Cancer Institute has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.
Sponsors: Astellas Pharma Global Development, Inc..
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rhode Island Hospital-Lifespan Cancer Institute has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rhode Island Hospital-Lifespan Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer.
Rhode Island Hospital-Lifespan Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.